Safety Recall: Kowa Bifidobacterium Lacbee Tablets – Japan CAA

Published by Reclia Safety Desk | June 29, 2026

Recall Information Record

Case Number: 00000035346
Product: Bifidobacterium Lacbee Tablets
Brand: Kowa
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Kowa Co., Ltd. has issued a voluntary recall for its product “Bifidobacterium Lacbee Tablets” (ラックビー錠) after discovering that the active ingredient content does not meet the approved regulatory specifications. The recall was announced on the Japan Consumer Affairs Agency (CAA) recall information site under management number 00000035346.

This non-compliance with approved standards may affect the product’s efficacy and safety, potentially posing health risks to consumers who rely on this probiotic supplement for digestive health. The recall underscores the importance of strict quality control in pharmaceutical and supplement manufacturing.

Consumers who have purchased this product are advised to take the following steps:

• Check the product label for the brand name “Kowa” and product name “Bifidobacterium Lacbee Tablets”.
• Discontinue use immediately and contact Kowa’s customer service for return and refund instructions.
• Monitor for any adverse health effects and consult a healthcare professional if needed.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

Recall initiated on June 1, 2026, due to active ingredient content deviating from approved specifications. Reference source: PMDA. Management number: 00000035346.

❓ Frequently Asked Questions